Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes-Reference-Cited by-同舟云学术

Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes

Published:2019-07 Issue:7 Volume:25 Page:1395-1406
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bramanti Stefania,Calafiore Valeria^ORCID,Longhi Elena,Mariotti Jacopo,Crespiatico Loretta,Sarina Barbara,De Philippis Chiara^ORCID,Nocco Angela,Santoro Armando,Castagna Luca

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference37 articles.

1. Allogeneic transplantation across major HLA barriers;Henslee-Downey;Best Pract Res Clin Haematol,2001

2. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation;Luznik;Semin Oncol,2012

3. Graft failure after allogeneic hematopoietic cell transplantation;Mattsson;Biol Blood Marrow Transplant,2008

4. Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease;Al-Homsi;Biol Blood Marrow Transplant,2015

5. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation;Ciurea;Transplantation,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies;Transplantation and Cellular Therapy;2024-09

2. Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-09

3. The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center;Frontiers in Oncology;2024-08-21

4. Secondary failure of lentiviral vector gene therapy in a cerebral adrenoleukodystrophy patient with an ABCD1 whole-gene deletion;Molecular Therapy;2024-08

5. Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis;Bone Marrow Transplantation;2024-07-27